The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
D000361:Agammaglobulinemia / Q000276:immunology; D001665:Binding Sites; D003167:Complement Activation; D003176:Complement C3 / Q000378:metabolism; D050577:Complement C3-C5 Convertases; D003180:Complement C3b Inactivator Proteins; D003182:Complement C5; D011415:Complement Factor B / Q000378:metabolism; D003170:Complement Pathway, Alternative; D005916:Globulins; D006801:Humans; D007074:Immunoglobulin G; D007700:Kinetics; D015054:Zymosan / Q000494:pharmacology*
D003176:Complement C3; D003180:Complement C3b Inactivator Proteins; D003182:Complement C5; D005916:Globulins; D007074:Immunoglobulin G; D015054:Zymosan; D050577:Complement C3-C5 Convertases; D011415:Complement Factor B